Search: onr:"swepub:oai:DiVA.org:kth-323277" >
Developments in the...
-
Damiati, Laila A.Department of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia;Centre for the Cellular Microenvironment, University of Glasgow, Glasgow, United Kingdom
(author)
Developments in the use of microfluidics in synthetic biology
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
Elsevier BV,2022
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:kth-323277
-
https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-323277URI
-
https://doi.org/10.1016/B978-0-12-824469-2.00025-7DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:vet swepub-contenttype
-
Subject category:kap swepub-publicationtype
Notes
-
Part of book: ISBN 978-0-12-824469-2QC 20230124
-
Biomimetics aims to copy and imitate natural elements and systems in a simpler form to overcome the limitations of complex biological elements and systems. The construction of biomimetic platforms to investigate physiological conditions requires an understanding of the native structure of cells and tissues and their interactions. Thus synthetic biology effectively connects biology and engineering. The engineering of custom cells/organs involves the construction of seminatural models that either perform existing functions in a modified manner or perform functions that do not exist naturally. In addition to providing an understanding of biological approaches, artificial models allow the mimicking of human physiology and diseases, facilitating the discovery of new drugs. Microfluidics is one of the most advanced technologies that allow the studying, mimicking, and manipulation of biological behaviors. Microfluidic devices are miniaturized devices that are functionally integrated on a single platform. The continuous development of microfluidic technology has led to the generation of artificial cells/organs that are based on in vivo mimetic models. Hence, it offers promising approaches for drug analysis, investigation of diseases and toxicity pathways, and construction of artificial models and even synthetic cell/organ chassis. This chapter presents microfluidic innovations for cell-like and organ-like architectures that were developed to simplify the complex networks of cells and organs. The merging of synthetic biology and microfluidics has led to the successful generation of artificial cells and organ-on-a-chip models. These biomimetic microfluidic environments have reduced the technical difficulties that acted as obstacles to studying cellular biology, have allowed the investigation of cell-cell, cell-tissue, and organ-like interfaces, and have aided the discovery of new therapeutic agents.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Damiati, Safa A.Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
(author)
-
Damiati, SamarKTH,Science for Life Laboratory, SciLifeLab,Nanobioteknologi,Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia(Swepub:kth)PI000000
(author)
-
Department of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia;Centre for the Cellular Microenvironment, University of Glasgow, Glasgow, United KingdomDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
(creator_code:org_t)
Related titles
-
In:New Frontiers and Applications of Synthetic Biology: Elsevier BV, s. 423-435
Internet link
Find in a library
To the university's database